Literature DB >> 29677635

Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2).

Le-Mao Yu1, Zhu Hu1, Yu Chen1, Azhar Ravji2, Sophia Lopez2, Caroline B Plescia2, Qian Yu1, Hui Yang1, Monica Abdelmalak2, Sourav Saha2, Keli Agama2, Evgeny Kiselev2, Christophe Marchand2, Yves Pommier2, Lin-Kun An3.   

Abstract

Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a recently discovered enzyme specifically repairing topoisomerase II (TOP2)-mediated DNA damage. It has been shown that inhibition of TDP2 synergize with TOP2 inhibitors. Herein, we report the discovery of the furoquinolinedione chemotype as a suitable skeleton for the development of selective TDP2 inhibitors. Compound 1 was identified as a TDP2 inhibitor as a result of screening our in-house compound library for compounds selective for TDP2 vs. TDP1. Further SAR studies provide several selective TDP2 inhibitors at low-micromolar range. The most potent compound 74 shows inhibitory activity with IC50 of 1.9 and 2.1 μM against recombinant TDP2 and TDP2 in whole cell extracts (WCE), respectively.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  DNA repair; Furoquinolinedione; Inhibitor; Topoisomerase; Tyrosyl-DNA phosphodiesterase

Mesh:

Substances:

Year:  2018        PMID: 29677635      PMCID: PMC5930004          DOI: 10.1016/j.ejmech.2018.04.024

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  37 in total

1.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

2.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

3.  Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives.

Authors:  Yu Cheng; Lin-Kun An; Ning Wu; Xiao-Dong Wang; Xian-Zhang Bu; Zhi-Shu Huang; Lian-Quan Gu
Journal:  Bioorg Med Chem       Date:  2008-02-15       Impact factor: 3.641

4.  Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2).

Authors:  Jayakanth Kankanala; Christophe Marchand; Monica Abdelmalak; Hideki Aihara; Yves Pommier; Zhengqiang Wang
Journal:  J Med Chem       Date:  2016-03-07       Impact factor: 7.446

Review 5.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

6.  Tyrosyl DNA phosphodiesterase 2, an enzyme fit for purpose.

Authors:  Keith W Caldecott
Journal:  Nat Struct Mol Biol       Date:  2012-12       Impact factor: 15.369

7.  TDP2/TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage.

Authors:  Zhihong Zeng; Felipe Cortés-Ledesma; Sherif F El Khamisy; Keith W Caldecott
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

8.  Depletion of tyrosyl DNA phosphodiesterase 2 activity enhances etoposide-mediated double-strand break formation and cell killing.

Authors:  Yasemin Saygideger Kont; Arijit Dutta; Apurva Mallisetty; Jeena Mathew; Tsion Minas; Christina Kraus; Priyanka Dhopeshwarkar; Bhaskar Kallakury; Sankar Mitra; Aykut Üren; Sanjay Adhikari
Journal:  DNA Repair (Amst)       Date:  2016-05-07

9.  Reversal of DNA damage induced Topoisomerase 2 DNA-protein crosslinks by Tdp2.

Authors:  Matthew J Schellenberg; Lalith Perera; Christina N Strom; Crystal A Waters; Brinda Monian; C Denise Appel; Caroline K Vilas; Jason G Williams; Dale A Ramsden; R Scott Williams
Journal:  Nucleic Acids Res       Date:  2016-04-08       Impact factor: 16.971

10.  Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2.

Authors:  Peter Hornyak; Trevor Askwith; Sarah Walker; Emilia Komulainen; Michael Paradowski; Lewis E Pennicott; Edward J Bartlett; Nigel C Brissett; Ali Raoof; Mandy Watson; Allan M Jordan; Donald J Ogilvie; Simon E Ward; John R Atack; Laurence H Pearl; Keith W Caldecott; Antony W Oliver
Journal:  Biochem J       Date:  2016-04-20       Impact factor: 3.857

View more
  3 in total

1.  Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.

Authors:  Evgeny Kiselev; Azhar Ravji; Jayakanth Kankanala; Jiashu Xie; Zhengqiang Wang; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2019-11-06

Review 2.  Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution.

Authors:  Amanda A Riccio; Matthew J Schellenberg; R Scott Williams
Journal:  Cell Mol Life Sci       Date:  2019-11-15       Impact factor: 9.261

3.  Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide.

Authors:  Jayakanth Kankanala; Carlos J A Ribeiro; Evgeny Kiselev; Azhar Ravji; Jessica Williams; Jiashu Xie; Hideki Aihara; Yves Pommier; Zhengqiang Wang
Journal:  J Med Chem       Date:  2019-04-30       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.